Skip to main content
. 2017 Aug 31;14(5):5631–5637. doi: 10.3892/ol.2017.6854

Figure 3.

Figure 3.

Upregulation of miR-18b promotes OC cell invasion. (A) Transwell assays indicated marked cell invasion inhibition in miR-18b inhibitor-treated ES-2 and HO8910 cells, compared with the inhibitor negative control-treated cells. (B) Invasive effect of miR-18b mimic- or mimic negative control-transfected ES-2 and HO8910 cells. *P<0.05. OC, ovarian cancer; miR, microRNA.